Selected research
Market Structure
Global Gene Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gene Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Gene Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gene Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gene Service include LipExoGen Biotech, Synbio Technologies, Genscript Biotech Corporation, Creative Biogene, GENEWIZ, Bio-Techne, Charles River Laboratories, Geneservice and Boston Medical Center, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Gene Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Gene Service Segment by Company
LipExoGen Biotech
Synbio Technologies
Genscript Biotech Corporation
Creative Biogene
GENEWIZ
Bio-Techne
Charles River Laboratories
Geneservice
Boston Medical Center
DefiGEN
NHS England
Integrated DNA Technologies
Blossom
Aldevron
Biocytogen
Gene Service Segment by Type
Gene Synthesis
Gene Cloning
Gene Mutagenesis
Gene Regulation
Gene Service Segment by Application
Medical
Biological
Gene Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Service industry.
Chapter 3: Detailed analysis of Gene Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Synthesis
- Gene Cloning
- Gene Mutagenesis
- Gene Regulation
Applications
- Medical
- Biological
Companies covered
- LipExoGen Biotech
- Synbio Technologies
- Genscript Biotech Corporation
- Creative Biogene
- GENEWIZ
- Bio-Techne
- Charles River Laboratories
- Geneservice
- Boston Medical Center
- DefiGEN
- NHS England
- Integrated DNA Technologies
- Blossom
- Aldevron
- Biocytogen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Gene Synthesis
- 1.2.3 Gene Cloning
- 1.2.4 Gene Mutagenesis
- 1.2.5 Gene Regulation
- 1.3 Market Analysis by Application
- 1.3.1 Global Gene Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Biological
- 1.4 Global Market Growth Prospects
- 1.5 Global Gene Service Growth Trends by Region
- 1.5.1 Global Gene Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Gene Service Market Size by Region (2021-2026)
- 1.5.3 Gene Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Gene Service Market Dynamics
- 2.1 Gene Service Industry Trends
- 2.2 Gene Service Industry Drivers
- 2.3 Gene Service Industry Opportunities and Challenges
- 2.4 Gene Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Gene Service Revenue by Company (2021-2026)
- 3.2 Global Gene Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Gene Service Key Company Head office and Area Served
- 3.4 Global Gene Service Company, Product Type & Application
- 3.5 Global Gene Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Gene Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Gene Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Gene Service Tier 1, Tier 2, and Tier 3
4 Gene Service Market by Type
- 4.1 Global Gene Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Gene Service Market Size by Type (2021-2032)
- 4.3 Global Gene Service Market Size Share by Type (2021-2032)
5 Gene Service Market by Application
- 5.1 Global Gene Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Gene Service Market Size by Application (2021-2032)
- 5.3 Global Gene Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 LipExoGen Biotech
- 6.1.1 LipExoGen Biotech Company Information
- 6.1.2 LipExoGen Biotech Business Overview
- 6.1.3 LipExoGen Biotech Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 LipExoGen Biotech Gene Service Product Portfolio
- 6.1.5 LipExoGen Biotech Recent Developments
- 6.2 Synbio Technologies
- 6.2.1 Synbio Technologies Company Information
- 6.2.2 Synbio Technologies Business Overview
- 6.2.3 Synbio Technologies Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Synbio Technologies Gene Service Product Portfolio
- 6.2.5 Synbio Technologies Recent Developments
- 6.3 Genscript Biotech Corporation
- 6.3.1 Genscript Biotech Corporation Company Information
- 6.3.2 Genscript Biotech Corporation Business Overview
- 6.3.3 Genscript Biotech Corporation Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Genscript Biotech Corporation Gene Service Product Portfolio
- 6.3.5 Genscript Biotech Corporation Recent Developments
- 6.4 Creative Biogene
- 6.4.1 Creative Biogene Company Information
- 6.4.2 Creative Biogene Business Overview
- 6.4.3 Creative Biogene Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Creative Biogene Gene Service Product Portfolio
- 6.4.5 Creative Biogene Recent Developments
- 6.5 GENEWIZ
- 6.5.1 GENEWIZ Company Information
- 6.5.2 GENEWIZ Business Overview
- 6.5.3 GENEWIZ Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 GENEWIZ Gene Service Product Portfolio
- 6.5.5 GENEWIZ Recent Developments
- 6.6 Bio-Techne
- 6.6.1 Bio-Techne Company Information
- 6.6.2 Bio-Techne Business Overview
- 6.6.3 Bio-Techne Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Bio-Techne Gene Service Product Portfolio
- 6.6.5 Bio-Techne Recent Developments
- 6.7 Charles River Laboratories
- 6.7.1 Charles River Laboratories Company Information
- 6.7.2 Charles River Laboratories Business Overview
- 6.7.3 Charles River Laboratories Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Charles River Laboratories Gene Service Product Portfolio
- 6.7.5 Charles River Laboratories Recent Developments
- 6.8 Geneservice
- 6.8.1 Geneservice Company Information
- 6.8.2 Geneservice Business Overview
- 6.8.3 Geneservice Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Geneservice Gene Service Product Portfolio
- 6.8.5 Geneservice Recent Developments
- 6.9 Boston Medical Center
- 6.9.1 Boston Medical Center Company Information
- 6.9.2 Boston Medical Center Business Overview
- 6.9.3 Boston Medical Center Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Boston Medical Center Gene Service Product Portfolio
- 6.9.5 Boston Medical Center Recent Developments
- 6.10 DefiGEN
- 6.10.1 DefiGEN Company Information
- 6.10.2 DefiGEN Business Overview
- 6.10.3 DefiGEN Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 DefiGEN Gene Service Product Portfolio
- 6.10.5 DefiGEN Recent Developments
- 6.11 NHS England
- 6.11.1 NHS England Company Information
- 6.11.2 NHS England Business Overview
- 6.11.3 NHS England Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 NHS England Gene Service Product Portfolio
- 6.11.5 NHS England Recent Developments
- 6.12 Integrated DNA Technologies
- 6.12.1 Integrated DNA Technologies Company Information
- 6.12.2 Integrated DNA Technologies Business Overview
- 6.12.3 Integrated DNA Technologies Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Integrated DNA Technologies Gene Service Product Portfolio
- 6.12.5 Integrated DNA Technologies Recent Developments
- 6.13 Blossom
- 6.13.1 Blossom Company Information
- 6.13.2 Blossom Business Overview
- 6.13.3 Blossom Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Blossom Gene Service Product Portfolio
- 6.13.5 Blossom Recent Developments
- 6.14 Aldevron
- 6.14.1 Aldevron Company Information
- 6.14.2 Aldevron Business Overview
- 6.14.3 Aldevron Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Aldevron Gene Service Product Portfolio
- 6.14.5 Aldevron Recent Developments
- 6.15 Biocytogen
- 6.15.1 Biocytogen Company Information
- 6.15.2 Biocytogen Business Overview
- 6.15.3 Biocytogen Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Biocytogen Gene Service Product Portfolio
- 6.15.5 Biocytogen Recent Developments
7 North America
- 7.1 North America Gene Service Market Size (2021-2032)
- 7.2 North America Gene Service Market Size by Type
- 7.2.1 North America Gene Service Market Size by Type (2021-2026)
- 7.2.2 North America Gene Service Market Size by Type (2027-2032)
- 7.2.3 North America Gene Service Market Share by Type (2021-2032)
- 7.3 North America Gene Service Market Size by Application
- 7.3.1 North America Gene Service Market Size by Application (2021-2026)
- 7.3.2 North America Gene Service Market Size by Application (2027-2032)
- 7.3.3 North America Gene Service Market Share by Application (2021-2032)
- 7.4 North America Gene Service Market Size by Country
- 7.4.1 North America Gene Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Gene Service Market Size by Country (2021-2026)
- 7.4.3 North America Gene Service Market Size by Country (2027-2032)
- 7.4.4 North America Gene Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Gene Service Market Size (2021-2032)
- 8.2 Europe Gene Service Market Size by Type
- 8.2.1 Europe Gene Service Market Size by Type (2021-2026)
- 8.2.2 Europe Gene Service Market Size by Type (2027-2032)
- 8.2.3 Europe Gene Service Market Share by Type (2021-2032)
- 8.3 Europe Gene Service Market Size by Application
- 8.3.1 Europe Gene Service Market Size by Application (2021-2026)
- 8.3.2 Europe Gene Service Market Size by Application (2027-2032)
- 8.3.3 Europe Gene Service Market Share by Application (2021-2032)
- 8.4 Europe Gene Service Market Size by Country
- 8.4.1 Europe Gene Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Gene Service Market Size by Country (2021-2026)
- 8.4.3 Europe Gene Service Market Size by Country (2027-2032)
- 8.4.4 Europe Gene Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Gene Service Market Size (2021-2032)
- 9.2 China Gene Service Market Size by Type
- 9.2.1 China Gene Service Market Size by Type (2021-2026)
- 9.2.2 China Gene Service Market Size by Type (2027-2032)
- 9.2.3 China Gene Service Market Share by Type (2021-2032)
- 9.3 China Gene Service Market Size by Application
- 9.3.1 China Gene Service Market Size by Application (2021-2026)
- 9.3.2 China Gene Service Market Size by Application (2027-2032)
- 9.3.3 China Gene Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Gene Service Market Size (2021-2032)
- 10.2 Asia Gene Service Market Size by Type
- 10.2.1 Asia Gene Service Market Size by Type (2021-2026)
- 10.2.2 Asia Gene Service Market Size by Type (2027-2032)
- 10.2.3 Asia Gene Service Market Share by Type (2021-2032)
- 10.3 Asia Gene Service Market Size by Application
- 10.3.1 Asia Gene Service Market Size by Application (2021-2026)
- 10.3.2 Asia Gene Service Market Size by Application (2027-2032)
- 10.3.3 Asia Gene Service Market Share by Application (2021-2032)
- 10.4 Asia Gene Service Market Size by Country
- 10.4.1 Asia Gene Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Gene Service Market Size by Country (2021-2026)
- 10.4.3 Asia Gene Service Market Size by Country (2027-2032)
- 10.4.4 Asia Gene Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Gene Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Gene Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Gene Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Gene Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Gene Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Gene Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Gene Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Gene Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Gene Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Gene Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Gene Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Gene Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Gene Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Gene Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst